All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
COPENHAGEN – Given the central role of Copenhagen in the industrialization of insulin production almost a century ago and given its ongoing strength in diabetes through the presence of global leader Novo Nordisk A/S, it was fitting that the region's next generation of contenders was invited to pitch its wares at a metabolic disease showcase on the final day of BIO-Europe.